FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 70525 - Interagency Breast Cancer and Environmental Research Coordinating Committee - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	Interagency Breast Cancer and Environmental Research Coordinating Committee	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	70525
Original Establishment Date	9/25/2009	Committee Status	Administratively Inactive
Actual Termination Date		Committee URL
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	0
Terminated This FY	No	Designated Fed Officer Position Title*	Director, Office of Scientific Coordination, Planning and Evaluation, NIEHS
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	9/25/2011	Designated Federal Officer First Name*	Gwen
Date Of Renewal Charter	9/25/2013	Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	Collman
Exempt From Renewal*	No	Designated Federal Officer Suffix	Ph.D.
Specific Termination Authority		Designated Federal Officer Phone*	(984) 287-3249
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Fax*	919-541-2843
Specific Establishment Authority*	42 USC 285a-12, section 417F, PHSA, as amended	Designated Federal Officer Email*	collmang@mail.nih.gov
Effective Date Of Authority*	10/8/2008
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	Yes
Legislation Status	Pending
How does cmte accomplish its purpose?*	NA
How is membership balanced?*	NA
How frequent & relevant are cmte mtgs?*	NA
Why advice can't be obtained elsewhere?*	NA
Why close or partially close meetings?	NA
Recommendation Remarks	The final report was submitted to the Secretary, HHS in January 2013. This is a statutory committee that has completed the task it was charged with in legislation, and is administratively inactive. In FY2019, this committee was recommended for termination by HHS to OMB under Executive Order 13875. The committee did not meet, there are no members, or reports in FY25. This committee does not have a public website. Because this committee is administratively inactive, the positions of committee designated federal official and committee decision maker are held by the same individual.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	No	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	No	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	NA
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	NA	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	N/A. The committee did not meet in FY24.	Grants Review Comment	N/A
Number Of Recommendations*	17	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Based on its review of the state of the science, current programs and investments by federal agencies and non-governmental organizations, and relevant communication efforts and policies, the Interagency Breast Cancer and Environmental Research Coordinating Committee has provided a comprehensive report summarizing its findings and seven recommendations to highlight the need for coordinated, targeted efforts to identify and mitigate the environmental causes of breast cancer. The report and recommendations were submitted to the Secretary, HHS in January 2013.	Access Agency Website	No
% of Recs Fully Implemented*	0.00%	Access Committee Website	No
% of Recs Fully Implemented Comment	The Committee's primary mission was to facilitate the efficient and effective exchange of information on breast cancer research activities among the member agencies, and to advise the NIH and other Federal agencies in the solicitation of proposals for collaborative, multidisciplinary research, including proposals to further evaluate environmental and genomic factors that may be related to the etiology of breast cancer. The Committee served as a forum and assisted in increasing public understanding of the member agencies' activities, programs, policies, and research, and in bringing important matters of interest forward for discussion.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	The Committee's primary mission was to facilitate the efficient and effective exchange of information on breast cancer research activities among the member agencies, and to advise the NIH and other Federal agencies in the solicitation of proposals for collaborative, multidisciplinary research, including proposals to further evaluate environmental and genomic factors that may be related to the etiology of breast cancer. The Committee served as a forum and assisted in increasing public understanding of the member agencies' activities, programs, policies, and research, and in bringing important matters of interest forward for discussion.	Access Other	No
Agency Feedback*	Not Applicable	Access Comment	NA
Agency Feedback Comment*	NA	Narrative Description*	This committee is recommended for termination.

COSTS

1. Payments to Non-Federal Members*	$0.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$0.00
2. Payments to Federal Members*	$0.00	2. Est. Payments to Fed Members Next FY*	$0.00
3. Payments to Federal Staff*	$0.00	3. Estimated Payments to Federal Staff*	$0.00
4. Payments to Consultants*	$0.00	4. Est. Payments to Consultants Next FY*	$0.00
5. Travel Reimb. For Non-Federal Membrs*	$0.00	5. Est Travel Reimb Non-Fed Membr nxtFY*	$0.00
6. Travel Reimb. For Federal Members*	$0.00	6. Est Travel Reimb For Fed Members*	$0.00
7. Travel Reimb. For Federal Staff*	$0.00	7. Est. Travel Reimb to Fed Staf Nxt FY*	$0.00
8. Travel Reimb. For Consultants*	$0.00	8. Est Travel Reimb to Consltnts Nxt FY*	$0.00
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	8/14/2025 8:18 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Medicine Health and Health Research

Custom Links

Committee Level Reports